Keith J. Sullivan
Net Worth

Last updated:

What is Keith J. Sullivan net worth?

The estimated net worth of Mr. Keith J. Sullivan is at least $9,028,464 as of 18 Jul 2024. He owns shares worth $4,502,804 as insider, has earned $914,980 from insider trading and has received compensation worth at least $3,610,680 in Neuronetics, Inc. and Sientra, Inc..

What is the salary of Keith J. Sullivan?

Mr. Keith J. Sullivan salary is $832,670 per year as Pres, Chief Executive Officer & Director in Neuronetics, Inc.. He also receives $40,000 as Director & Advisor to MiraDry Bus. in Sientra, Inc..

How old is Keith J. Sullivan?

Mr. Keith J. Sullivan is 67 years old, born in 1958.

What stocks does Keith J. Sullivan currently own?

As insider, Mr. Keith J. Sullivan owns shares in 2 companies:

Company Title Shares Price per share Total value
Neuronetics, Inc. (STIM) Pres, Chief Executive Officer & Director 1,324,354 $3.4 $4,502,804
Sientra, Inc. (SIEN) Director & Advisor to MiraDry Bus. 203,141 $0 $0

What does Neuronetics, Inc. do?

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

What does Sientra, Inc. do?

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.

Keith J. Sullivan insider trading

Neuronetics, Inc.

Mr. Keith J. Sullivan has made 19 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 24,162 units of STIM stock worth $45,908 on 18 Jul 2024.

The largest trade he's ever made was exercising 100,000 units of STIM stock on 20 Oct 2022. As of 18 Jul 2024 he still owns at least 1,324,354 units of STIM stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 24,162 $1.9 $45,908
Sale
Common Stock 11,687 $1.97 $23,023
Sale
Common Stock 12,075 $1.91 $23,063
Sale
Common Stock 20,292 $3.3 $66,964
Sale
Common Stock 20,750 $3.23 $67,023
Sale
Common Stock 20,851 $3.23 $67,349
Sale
Common Stock 23,958 $2.96 $70,916
Sale
Common Stock 9,516 $3.16 $30,071
Sale
Common Stock 10,013 $3.01 $30,139
Sale
Common Stock 6,551 $2.04 $13,364
Sale
Common Stock 6,510 $2.06 $13,411
Sale
Common Stock 6,479 $2.07 $13,412
Sale
Common Stock 13,647 $5.58 $76,150
Sale
Common Stock 25,154 $5.49 $138,095
Option
Common Stock 100,000 $1.98 $198,000
Option
Employee Stock Option (right to buy) 100,000 $1.98 $198,000
Sale
Common Stock 63,466 $3.72 $236,094
Sale
Common Stock 93 N/A N/A
Sale
Common Stock 50,893 N/A N/A
Sale
Common Stock 45,632 N/A N/A
Sale
Common Stock 22,829 N/A N/A

Sientra, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 20,869 $5.75 $119,997
Purchase
Common Stock 7,407 $13.5 $99,995

Neuronetics key executives

Neuronetics, Inc. executives and other stock owners filed with the SEC:

  • Mr. Keith J. Sullivan (67) Pres, Chief Executive Officer & Director
  • Mr. Stephen J. Furlong M.S. (60) Senior Vice President, Chief Financial Officer & Treasurer
  • Mr. W. Andrew Macan (52) Senior Vice President, Gen. Counsel, Chief Compliance Officer, Sec. & Member of Office of the Pres